Trajectories of self-reported dyspnoea, physical fatigue, and cognitive symptoms after hospitalization for COVID-19 - a nationwide registry study from Norway

Abstract Background The purpose of this study is to assess trajectories and prognostic factors for self-reported symptoms consistent with long COVID at 3 and 12 months after hospitalization for COVID-19. Methodology In a prospective, nationwide registry study in Norwegian patients hospitalized for COVID-19 from March to December 2020, we analysed patient-reported outcomes using the modified Medical Research Council dyspnoea scale (mMRC) and the 11-item Chalder Fatigue Questionnaire (CFQ) completed online by participants three ( n = 657) and twelve months ( n = 647) after hospital discharge. We used generalized estimating equations to assess trajectories of, and prognostic factors for self-reported dyspnoea, fatigue, and specific cognitive symptoms including problems with concentration (CFQ8), verbal control (CFQ9), word retrieval (CFQ10), and memory (CFQ11). Results Participants’ mean age was 58.9 years (standard deviation SD 14.2), and 40.9% (275/673) were female. The prevalence of self-reported dyspnoea (mMRC ≥ 2) was 24.6% (151/615) at three and 22.0% (134/609) at twelve months, with no significant change in mMRC score (estimate −0.023, 95% confidence interval [CI] −0.099 to 0.054). Prevalence of self-reported physical fatigue (≥10 on 21-point scale of CFQ item 1–7) decreased from 62.3% (369/592) at three months to 60.4% (349/578) at twelve months (estimate −0.346, 95% CI −0.637 to −0.054, prevalence 62.3% to 60.4%). Self-reported specific cognitive symptoms, including problems with concentration (CFQ8), verbal control (CFQ9), word retrieval (CFQ10), and memory (CFQ11), assessed as a combined score of ≥ 6 on 12-point scale of CFQ items 8–11, increased significantly from 35.2% (211/599) to 46.6% (247/578, estimate 0.856, CI 0.663 to 1.050). Prognostic factors for self-reported dyspnoea were smoking (estimate 0.57, 95% 0.12 to 1.03), asthma/lung disease (estimate 0.34, 95% CI 0.18 to 0.50), neurological disease (estimate 0.56, 95% CI 0.01 to 1.10), liver disease (estimate 0.93, 95% CI 0.00 to 1.87), and prolonged hospital stay (estimate 0.02, 95% CI 0.01 to 0.03). Prognostic factors for self-reported physical fatigue were immunodeficiency (estimate 1.80, 95% CI 0.30 to 3.30), liver disease (estimate 4.08, 95% CI 2.68 to 5.49) and prolonged hospital stay (estimate 0.05, 95% CI 0.01 to 0.08). Smoking (estimate 1.00, 95% CI 0.00 to 1.99) was a prognostic factor for self-reported cognitive symptoms. Older age was associated with lower risk of self-reported physical fatigue (estimate −0.05, 95% CI −0.08 to −0.02) and cognitive symptoms (estimate −0.03, 95% CI −0.04 to −0.01). Conclusion While self-reported physical fatigue improves, it is worrying that self-reported problems with concentration and memory significantly worsen from three to twelve months.

Authors

Institutions

Publication Details

Journal
Journal of Patient-Reported Outcomes
Published
2026-11-17
DOI
https://doi.org/10.1186/s41687-026-01259-y
Primary Topic
Long-Term Effects of COVID-19
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Trajectories of self-reported dyspnoea, physical fatigue, and cognitive symptoms after hospitalization for COVID-19 - a nationwide registry study from Norway

Ingrid Bergliot Helland, Marjolein M. Iversen, Eirik Alnes Buanes, Bjørn Blomberg et al.
1 links
Journal of Patient-Reported Outcomes
Long-Term Effects of COVID-19
article

Trajectories of self-reported dyspnoea, physical fatigue, and cognitive symptoms after hospitalization for COVID-19 - a nationwide registry study from Norway

Ingrid Bergliot Helland, Marjolein M. Iversen, Eirik Alnes Buanes, Bjørn Blomberg, Elisabeth Berg Fjelltveit, Rebecca Jane Cox, Nina Langeland, Helene Kolle Tvedt, Marie Sollesnes
article en

Abstract

Abstract Background The purpose of this study is to assess trajectories and prognostic factors for self-reported symptoms consistent with long COVID at 3 and 12 months after hospitalization for COVID-19. Methodology In a prospective, nationwide registry study in Norwegian patients hospitalized for COVID-19 from March to December 2020, we analysed patient-reported outcomes using the modified Medical Research Council dyspnoea scale (mMRC) and the 11-item Chalder Fatigue Questionnaire (CFQ) completed online by participants three ( n = 657) and twelve months ( n = 647) after hospital discharge. We used generalized estimating equations to assess trajectories of, and prognostic factors for self-reported dyspnoea, fatigue, and specific cognitive symptoms including problems with concentration (CFQ8), verbal control (CFQ9), word retrieval (CFQ10), and memory (CFQ11). Results Participants’ mean age was 58.9 years (standard deviation SD 14.2), and 40.9% (275/673) were female. The prevalence of self-reported dyspnoea (mMRC ≥ 2) was 24.6% (151/615) at three and 22.0% (134/609) at twelve months, with no significant change in mMRC score (estimate −0.023, 95% confidence interval [CI] −0.099 to 0.054). Prevalence of self-reported physical fatigue (≥10 on 21-point scale of CFQ item 1–7) decreased from 62.3% (369/592) at three months to 60.4% (349/578) at twelve months (estimate −0.346, 95% CI −0.637 to −0.054, prevalence 62.3% to 60.4%). Self-reported specific cognitive symptoms, including problems with concentration (CFQ8), verbal control (CFQ9), word retrieval (CFQ10), and memory (CFQ11), assessed as a combined score of ≥ 6 on 12-point scale of CFQ items 8–11, increased significantly from 35.2% (211/599) to 46.6% (247/578, estimate 0.856, CI 0.663 to 1.050). Prognostic factors for self-reported dyspnoea were smoking (estimate 0.57, 95% 0.12 to 1.03), asthma/lung disease (estimate 0.34, 95% CI 0.18 to 0.50), neurological disease (estimate 0.56, 95% CI 0.01 to 1.10), liver disease (estimate 0.93, 95% CI 0.00 to 1.87), and prolonged hospital stay (estimate 0.02, 95% CI 0.01 to 0.03). Prognostic factors for self-reported physical fatigue were immunodeficiency (estimate 1.80, 95% CI 0.30 to 3.30), liver disease (estimate 4.08, 95% CI 2.68 to 5.49) and prolonged hospital stay (estimate 0.05, 95% CI 0.01 to 0.08). Smoking (estimate 1.00, 95% CI 0.00 to 1.99) was a prognostic factor for self-reported cognitive symptoms. Older age was associated with lower risk of self-reported physical fatigue (estimate −0.05, 95% CI −0.08 to −0.02) and cognitive symptoms (estimate −0.03, 95% CI −0.04 to −0.01). Conclusion While self-reported physical fatigue improves, it is worrying that self-reported problems with concentration and memory significantly worsen from three to twelve months.

Journal of Patient-Reported Outcomes
Oslo University Hospital (NO), Western Norway University of Applied Sciences (NO), Haukeland University Hospital (NO), University of Bergen (NO)
Universitetet i Bergen
Good health and well-being
Long-Term Effects of COVID-19
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon